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Malaria is caused by parasites of the genus Plasmodium. All human-infecting 25 
Plasmodium species can establish long-lasting chronic infections1-5, creating an 26 
infectious reservoir to sustain transmission1,6. It is widely accepted that maintenance 27 
of chronic infection involves evasion of adaptive immunity by antigenic variation7. 28 
However, genes involved in this process have been identified in only two of five 29 
human-infecting species: P. falciparum and P. knowlesi. Furthermore, little is 30 
understood about the early events in establishment of chronic infection in these 31 
species. Using a rodent model we demonstrate that only a minority of parasites from 32 
among the infecting population, expressing one of several clusters of virulence-33 
associated pir genes, establishes a chronic infection. This process occurs in different 34 
species of parasite and in different hosts. Establishment of chronicity is independent 35 
of adaptive immunity and therefore different from the mechanism proposed for 36 
maintainance of chronic P. falciparum infections7-9. Furthermore, we show that the 37 
proportions of parasites expressing different types of pir genes regulate the time 38 
taken to establish a chronic infection. Since pir genes are common to most, if not all, 39 
species of Plasmodium10, this process may be a common way of regulating the 40 
establishment of chronic infections.  41 
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  42 
 Long-lasting Plasmodium falciparum infections are thought to be maintained by 43 
cytoadherence to avoid splenic clearance and antigenic variation of the adherent proteins 44 
to avoid clearance by antibodies. We wanted to know how chronic infections are 45 
established by malaria parasites lacking genes known to be involved in these processes 46 
(var and sicavar). We used, as an example, the rodent malaria parasite Plasmodium 47 
chabaudi chabaudi AS that gives rise to chronic infections in laboratory mice (Figure 48 
1A). The acute infection is defined by a peak of parasitaemia (5-10% iRBC) 49 
approximately ten days after mosquito bite, and clearance of the majority of parasites by 50 
day fifteen. A chronic infection is then established, giving rise to several episodes of 51 
patent parasitemia (>0.01%) for up to eighty days. Comparison of the transcriptomes of 52 
parasite populations from the acute and chronic phases of infection showed that among 53 
the multigene families identified in the P. chabaudi AS genome, the pir family is the 54 
most differentially expressed (Figure 1A, Supplementary Tables 1 and 2). This multigene 55 
family is present in most Plasmodium genomes11 and has been associated with 56 
virulence12. More than half of the pir genes were differentially expressed between acute 57 
and chronic phases. The majority of these genes had significantly higher expression in the 58 
acute phase of infection, whereas only a few had higher expression in the chronic phase.  59 
 A Plasmodium-specific antibody response is detectable from day seven of 60 
infection13 and thus the change in pir expression might be the result of adaptive 61 
immunity-dependent selection of parasites expressing certain pir genes. However, we 62 
observed the same change in mice lacking B cells and antibodies (μMT; Figure 1B) or 63 
lacking T cells able to promote an antibody response (TCRα-/-; Figure 1C; 64 
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Supplementary Figure 1; Supplementary Table 1). Therefore the transcriptomic changes 65 
observed between acute and chronic phases are independent of adaptive immunity and 66 
distinct from the mechanism suggested to be involved in maintenance of chronic 67 
infection in P. falciparum9.  68 
 In the genomes of most malaria parasites, pir genes are located in subtelomeric 69 
regions that are difficult to resolve based on the de novo assembly of short sequencing 70 
reads. Using Single Molecule Real-Time (SMRT) sequencing, we generated a new 71 
genome assembly for P. chabaudi AS comprising a complete set of fourteen 72 
chromosomes with no gaps (Supplementary Table 3). We observed that some 73 
subtelomeres had similar sets of pir genes arranged in clusters (Supplementary Figures 2 74 
and 3). In recent work, pir genes were classified into several short and long forms (S1-7 75 
and L1-4, respectively)14. We found eight clusters with common structures: three were 76 
enriched for the L1 subfamily and five were enriched for the S7 subfamily (Figure 2; 77 
Supplementary Table 4). Interestingly, we found that the majority of pir expression in our 78 
samples came from this small number of clusters, and that genes within clusters were co-79 
expressed during infection (Supplementary Figure 4). While the S7-rich clusters were 80 
highly expressed during the acute phase, the chronic phase was dominated by expression 81 
of L1-rich loci (Figure 2C; Supplementary Table 5). This pattern was replicated in the 82 
αβT-cell receptor- and B-cell knockout mice (Figure 2C) reinforcing our earlier 83 
conclusion that changes in pir gene expression are independent of selection by the 84 
adaptive immune response. Individual L1- or S7-rich loci are hereafter termed 85 
Chronicity-Associated Pir Locus (ChAPL), and Acute-Associated Pir Locus (AAPL), 86 
respectively. We identified an intergenic motif, commonly occurring upstream of most 87 
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ChAPL genes, that might serve as a promoter sequence (Supplementary Figure 5). 88 
However, as only a subgroup of ChAPL genes are expressed in each mouse (Figure 2C), 89 
it is likely that epigenetic mechanisms regulate access of transcription factors to this 90 
motif, as shown for subtelomeric gene families in P. falciparum15. Of the three ChAPLs, 91 
we observed a preference for clusters on chromosome 6.  92 
 We recently showed that increased P. chabaudi virulence during serial blood 93 
passage (SBP) is associated with a reduced repertoire of pir gene transcripts compared 94 
with parasites transmitted by mosquito (MT)12. The gene most highly upregulated in SBP 95 
parasites was a pir from the L1 subfamily (PCHAS_1100300). Although not found in a 96 
ChAPL, this gene is from the same subfamily that is most common in these loci. We 97 
therefore hypothesized that chronic phase parasites expressing ChAPLs would have a 98 
similar phenotype. To test this, we injected acute and chronic phase parasites into naïve 99 
mice. Chronic parasites gave rise to significantly greater parasitaemias and pathology 100 
than parasites derived from the acute phase of infection (Figure 3A; Supplementary 101 
Figure 6A). This suggests that parasite populations derived from the chronic phase 102 
expand better in the face of the response of a naive mouse than parasites derived from the 103 
acute phase. However, as chronic parasites only reached high parasitaemias when 104 
injected into naïve mice, our data also indicate that they are better controlled when the 105 
host has previously experienced an acute infection. This pattern was also observed when 106 
chronic parasites were collected from B-cell knockout mice (Supplementary Figure 6B). 107 
Chronic infections therefore involve the emergence of phenotypically distinct parasites 108 
expressing ChAPLs, independently of adaptive immunity. 109 
 6
 Thus we have established that there are transcriptional and phenotypic changes 110 
observed during chronic Plasmodium infections and that they do not stem from classical 111 
antigenic variation. We then sought to determine whether these were due to a 112 
transcriptional switch at the population level, or to a selection of pre-existing parasites 113 
from the acute phase. We isolated single parasites from the acute and chronic phases of 114 
infection, initiated clonal infections in C57Bl/6 mice and performed RNA sequencing 115 
analyses of these cloned populations of parasites (Figure 3B). We found that one out of 116 
ten acute-phase clones was more virulent than the population as a whole (Figure 3B; 117 
Supplementary Figure 7). While avirulent clones expressed AAPLs, the virulent clone 118 
expressed a ChAPL, as predicted by our finding that ChAPL-expressing parasites are 119 
more virulent in naïve mice (Figure 3C; Supplementary Figure 8; Supplementary Table 120 
6). As expected, the clones from the chronic phase were all virulent and expressed 121 
ChAPLs (Figures 3B & 3C, Supplementary Figures 8 & 9). This suggests that the 122 
establishment of chronic infection involves selection of a small proportion of parasites 123 
expressing ChAPLs from a clonally variant population largely expressing AAPLs. 124 
 On the basis of these observations, we hypothesized that the proportion of virulent 125 
parasites already in the acute phase might affect the success of establishing a chronic 126 
infection. In our initial transcriptome experiment, we found that high expression of 127 
ChAPLs during the acute phase was associated with a more rapid recrudescence 128 
(Supplementary Table 7). We then tested whether chronic-like parasites, expressing L1 129 
pir genes, outgrew acute parasites largely expressing AAPLs. We used SBP parasites as a 130 
proxy for chronic parasites as they express the L1 pir PCHAS_1100300, and have a 131 
similar phenotype to ChAPL-expressing chronic parasites. We performed mixed 132 
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infections in C57BL/6 mice with different ratios of SBP and acute MT (expressing 133 
AAPLs) parasites tagged with different fluorescent markers (Figure 4, Supplementary 134 
Figure 10 A-C; Supplementary Table 8). SBP parasites rapidly outcompeted MT 135 
parasites (Figure 4; Supplementary Figure 10D), confirming that the more virulent, 136 
chronic-like parasites had a selective advantage, as has been shown previously for 137 
different parasite isolates16-20. The selection of a minority of iRBCs, expressing 138 
virulence-associated pir genes (Figures 3B & 3C), can therefore explain the change in 139 
expression from S- to L-pir genes observed in the parasite population between the acute 140 
and chronic phases of infection (Figures 1 & 2).  As we had hypothesized, higher doses 141 
of L1-expressing parasites resulted in an earlier recrudescence confirming that these 142 
parasites have a better capacity to establish a chronic infection (Figure 4, Supplementary 143 
Figure 11). 144 
When a similar infection mixing SBP and MT parasites was carried out in RAG1-/- mice 145 
(lacking both T and B cells) and RAG-/- mice treated with chlodronate liposomes to 146 
deplete macrophages (Supplementary Figure 12A), virulent parasites similarly rapidly 147 
outgrew AAPL-expressing parasites. Thus, this early selection takes place even in the 148 
absence of B cells, T cells, and macrophages indicating that other mechanisms are 149 
operating (Supplementary Figure 12B).  150 
Unexpectedly, when mice were infected with 104 virulent parasites plus 105 151 
avirulent parasites, the acute parasitaemia and pathology were lower than in mice 152 
infected with 104 virulent parasites alone (Figure 4B, Supplementary Figure 11). This 153 
suggests that AAPL-expressing parasites act to lower the virulence of parasites 154 
expressing largely virulence-associated L1 pirs and delay the onset of chronicity. 155 
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Therefore, the initial composition of parasites expressing different pir genes regulates 156 
parasite recrudescence.  157 
To determine whether our findings apply more generally, beyond P. chabaudi AS 158 
infections of laboratory mice, we established chronic infections with alternative 159 
host/parasite combinations. We used the more virulent P. chabaudi CB strain in C57BL/6 160 
mice and P. chabaudi AS in the African thicket rat Grammomys surdaster. This is a 161 
natural host of rodent Plasmodium (Supplementary Figures 13A & 13B).  Reduced 162 
AAPL and increased ChAPL gene expression during chronic P. chabaudi infection were 163 
observed in both cases, suggesting that our findings are a general feature of P. chabaudi 164 
chronic infections irrespective of strain of parasite or host (Supplementary Figures 13C & 165 
13D). We then investigated chronic P. berghei infections in Brown Norway rats 166 
(Supplementary Figure 14A). The subtelomeric regions and pir repertoire of P. berghei 167 
are quite different from those of P. chabaudi 14. Loci resembling the AAPLs and ChAPLs 168 
of P. chabaudi are absent. Nevertheless, we observed a general decrease in pir expression 169 
during the chronic phase with an increase in expression of L2 pir genes (Supplementary 170 
Table 9; Supplementary Figure 14B). The L2 pir genes of P. berghei are similar to the P. 171 
chabaudi L1 genes we found in ChAPLs. They are present in recently copied loci 172 
(Supplementary Figure 14C), contain long variable central domains and have a longer N-173 
terminal domain that may contain a second transmembrane helix (Supplementary Figure 174 
15). This suggests our findings are a general feature of malaria parasites infecting rodents. 175 
Our results show that mosquito transmission of P. chabaudi gives rise to a 176 
clonally variant population of parasites, the majority expressing AAPLs and a minority 177 
ChAPLs. During the acute phase of infection, AAPL-expressing parasites are controlled 178 
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by the host response, while ChAPL-expressing parasites survive and establish a chronic 179 
infection. The more ChAPL-expressing parasites that are present early in infection, the 180 
more rapidly the chronic infection is established.  181 
 182 
While it is thought that maintenance of chronic P. falciparum infection depends 183 
on the differential expression of var genes7,8, how similar infections are established and 184 
maintained by P. vivax, P. malariae and P. ovale, that lack these variant antigens, is 185 
unknown. Here, we show that the establishment of chronic Plasmodium infection in 186 
rodent models is reproducibly associated with phenotypically distinct parasites, 187 
expressing particular pir gene clusters. Importantly, contrary to what is understood about 188 
maintenance of chronic infection in P. falciparum9, this change in the parasite population 189 
is independent of adaptive immunity. Antigenic variation may still operate in maintaining 190 
chronicity, but our results clearly show that other mechanisms allow for the establishment 191 
of chronic infection in parasites that infect rodents. 192 
Our finding that the initial population of parasites comprises individuals, each 193 
expressing different pir genes, suggests that the chronic infection is established by a 194 
small number of parasites which evade the early immune response. The selective 195 
advantage during infection of ChAPL-expressing over AAPL-expressing parasites could 196 
be of multiple origins. Although our previous results showed that growth rates of 197 
avirulent MT parasites and virulent SBP parasite were similar in RAG1-/- mice12, red cell 198 
invasion efficiency might still play a role in selection of virulent clones for establishment 199 
of chronic infection. We are also investigating rosette formation21,22, red cell 200 
deformability23, sequestration24, and the capacity to escape a macrophage-independent 201 
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innate immune response25 as possibilities. It has been shown that the expression of 202 
subsets of P. falciparum rif genes (which may be relatives of pir genes10) and P. vivax pir 203 
genes are associated with cytoadherence of iRBCs to human endothelial cells26,27 and red 204 
blood cells21,28,29, two processes implicated in parasite survival and pathogenicity30. 205 
Furthermore, it has previously been suggested that the same molecules are involved in 206 
cytoadherence and immune evasion in P. chabaudi9,24. Differences in cytoadhesive 207 
properties could therefore promote the expansion of more virulent parasites. 208 
Characterizing this process and determining the function of pir genes in vivo may identify 209 
mechanisms that universally regulate immune evasion by Plasmodium and lead to novel 210 
approaches to reduce their survival and transmission.  211 
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Methods 212 
 213 
Mouse and parasite lines used 214 
All experiments were performed in accordance with the UK Animals (Scientific 215 
Procedures) Act 1986 (PPL 80/2538) and the guidelines provided by the 216 
National Institutes of Health (NIH) Animal Care and Use Committee (ACUC) and 217 
approved by the Francis Crick Institute Ethical Committee and by the Institutional 218 
Animal Care and Use Committee (IACUC).  T cell receptor-α chain knockout (TCRα-/-219 
)31, mice homozygous for a targeted mutation of the transmembrane exon of the IgM μ 220 
chain, μMT32, and V(D)J recombination activation gene RAG-1 knockout (RAG-1-/-) 33 221 
on a C57Bl/6 background,  and   C57 Bl/6  Wildtype (WT) mice were obtained from the 222 
specific-pathogen free (SPF) unit and subsequently conventionally housed with 223 
autoclaved cages, bedding and food at the BRF, of the Francis Crick Institute. The 224 
Grammomys surdaster rats used in this study were captured in the wild at Fungurume and 225 
Lumata in the Katanga province, south of DR Congo, were bred and maintained in a 226 
conventional unit  in sterile cages, with autoclaved water and  bedding at 227 
NIH/NIAID/LMIV 34. Inbred Brown Norway rats were obtained from Charles River 228 
Laboratories and housed at the Animal Holding Unit of the Wellcome Trust Sanger 229 
Institute. Experiments were performed with 6-8 week old female mice and Grammomys 230 
surdaster rats housed under reverse light conditions (light 19:00-07:00, dark 07:00-231 
19:00) and 6-week old female Brown Norway rats housed under normal light conditions, 232 
at 20-22°C. Measurements of clinical pathology were taken at 11:00. Core body 233 
temperature was measured with a rectal thermometer and erythrocyte density was 234 
determined with a VetScan HMII haematology system (Abaxis). Changes in body 235 
 12
temperature, body weight and erythrocyte density were calculated relative to a baseline 236 
measurement performed 1 day before infection. An infection was considered virulent 237 
when it induced a statistically significant decrease in the mouse temperature, weight 238 
and/or red blood cells compared with uninfected control mice. 239 
Cloned lines of Plasmodium chabaudi chabaudi AS and CB parasites were used. To 240 
initiate infection, mice were either injected intraperitoneally (IP) or intravenously (IV) 241 
with 1, 104 or 105 infected erythrocytes or submitted to the bite of 20 infected mosquitoes 242 
as previously described12. Grammomys surdaster rats were infected by I.V. injection of 243 
2500 sporozoites of Plasmodium chabaudi chabaudi AS. Brown Norway rats were 244 
infected by I.V. injection of 7200 sporozoites of Plasmodium berghei ANKA. 245 
Parasitaemia was monitored by Giemsa-stained thin blood films on blinded samples. The 246 
limit of detection for patent parasitaemia was 0.001% infected erythrocytes.  247 
 248 
Chronic infections in wild type and genetically altered rodents 249 
Out of 10 wild-type C57Bl/6 mice, 10 μMT mice and 10 TCRα-/- mice infected with P. 250 
chabaudi AS via mosquito bite, 9 WT C57Bl/6 mice, 5 μMT mice and 3 TCRα-/- mice 251 
were randomly selected for transcriptomic analysis. 3 C57Bl/6 mice infected with P. 252 
chabaudi CB, 3 Grammomys surdaster rats infected with P. chabaudi AS and 3 Brown 253 
Norway rats infected with P. berghei ANKA (all via mosquito bites or injection of 254 
sporozoites) were also used for transcriptomic analysis. Our aim was to use a minimum 255 
of three biological replicates per condition for all experiments, as this is considered to be 256 
sufficient for general surveys of differential expression35. Blood was extracted from the 257 
same rodents at two time points, therefore analysing the changes occurring over time in 258 
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the same parasite populations. During the acute phase of infection, 100μL of blood was 259 
collected from the tail after the completion of seven cycles of schizogony. During the 260 
chronic phase, exsanguination was performed between 30 and 40 days post-infection in 261 
μMT mice, at 30 days post-infection in TCRα-/- mice, at day 15 post-infection in Brown 262 
Norway rats or when the parasitaemia reached 0.1% between 27 and 40 days post-263 
infection in wild type C57Bl/6 mice and G. surdaster rats. After data collection, the acute 264 
sample from wild-type mouse 454 and both acute and chronic samples from μMT mouse 265 
433 were excluded, as they were outliers in a multi-dimensional scaling analysis of the 266 
gene expression data. 267 
 268 
Phenotypic analysis of acute and chronic parasites  269 
Donor mice were infected via mosquito bites. Parasites from donor mice (n= 3) were 270 
blood-passaged into recipient mice  at 1, 3, 4 and 6 weeks post-mosquito transmission. 271 
Recipient mice (n=5 per donor mouse, the minimum number required for an 80% chance 272 
of significant differences (p<=0.05) in parasitemia, weight and erythrocyte counts) were 273 
infected by IP injection of 105 infected erythrocytes. Parasitaemia and signs of pathology 274 
were monitored in recipient mice on blinded samples. 275 
 276 
Cloning of single parasites from acute and chronic phases 277 
One mouse was infected via mosquito bite. Infected blood was then collected from the 278 
tail at two time points: 1 week post-infection (acute phase) and six weeks post-infection 279 
(chronic phase). Both times, parasites were cloned by dilution and single parasites were 280 
injected IV in wild type mice. After expansion, each cloned line was blood passaged into 281 
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eight experimental mice by IP injection of 105 infected erythrocytes. Five mice were used 282 
to monitor parasitaemia and signs of pathology and three mice were sacrificed and 283 
exsanguinated after the completion of seven cycles of schizogony for RNA extraction.  284 
 285 
RNA extraction 286 
During all RNA extractions experiments, blood-stage parasites were isolated at 11:00, 287 
when >90% of the parasites were at the late trophozoite stage of development (Table S8). 288 
Parasite RNA was isolated as previously described12. Briefly, whole blood was depleted 289 
of leukocytes by filtration (Plasmodipur, EuroProxima) and from globin RNA and red 290 
cell debris by saponin lysis (Sigma) and centrifugation. Purified parasites were 291 
resuspended in TRIzol, snap-frozen on dry ice and kept at -80°C until use. RNA was then 292 
extracted, resuspended in water and its quantity and quality were determined on an 293 
Agilent 2100 Bionalayzer RNA 6000 Nano or Pico chip. 294 
 295 
RNA-seq library prep and sequencing 296 
The majority of RNA was used to make 200-450bp fragment libraries using Illumina's 297 
TruSeq RNA Sample Prep v2 kit, with 10 cycles of PCR amplification using KAPA Hifi 298 
Polymerase rather than the kit-supplied Illumina PCR Polymerase. Two samples required 299 
14 cycles of PCR (T1_46-4 and T1_47-4). Mosquito-transmitted P. chabaudi CB 300 
samples (MTCB) were subjected to 15 cycles of PCR. 301 
The libraries were sequenced using an Illumina HiSeq 2000 v3 with 100bp paired-end 302 
reads (samples beginning ‘T’), an Illumina HiSeq 4000 with 75bp paired-end reads 303 
(MTCB samples) or an Illumina HiSeq 2500 with 75bp paired-end reads for the rest. 304 
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RNA from cloned parasites was used to make 100-300bp fragment libraries produced 305 
using Illumina’s TruSeq Stranded mRNA Sample Prep Kit with 10 cycles of PCR 306 
amplification using KAPA Hifi Polymerase. These libraries were sequenced using an 307 
Illumina HiSeq 2500 with 75bp paired-end reads. A description of the libraries can be 308 
found in Supplementary Table 10. 309 
 310 
 311 
Analysis of gene expression 312 
Tag sequences were removed from sequenced reads. Where individual samples were run 313 
over multiple lanes, the reads from these were merged before mapping. Reads were then 314 
mapped against spliced gene sequences (exons, but not UTRs) from the v3 P. c. chabaudi 315 
AS (this work) or the v3 P. berghei ANKA (Fougère et al., under review) reference 316 
genomes using Bowtie2 v2.1.036 (-a -X 800 –x). Read counts per transcript were 317 
estimated using eXpress v1.3.037, with default parameters.  Genes with an effective 318 
length cutoff below 10 in any sample were removed. Summing over transcripts generated 319 
read counts per gene. 320 
Differential expression analysis was performed using edgeR v3.8.638 on genes with ≥ 3 321 
counts per million. The Fisher’s exact test was used with cutoffs FDR < 0.01 and fold 322 
change ≥ 2, except for the P.berghei analysis where FDR < 0.1 and fold change ≥ 1 was 323 
used. Functional categories of genes were identified by orthology using GeneDB 39 from 324 
several different P. falciparum datasets: invasion genes40, sexual genes41 and 325 
subtelomeric (by manual inspection of chromosomes). 326 
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Gene expression clustering was used to identify which genes within ChAPLs and AAPLs 327 
were co-expressed. This was done by generating a toroidal 5x5 Self-Organising Map 328 
(SOM) using the Kohonen package in R42. FPKM values for each gene were logged (base 329 
2) and mean-normalised per gene. The SOM was trained in 100 iterations.  330 
 331 
Sequencing and assembly of P. c. chabaudi AS v3 genome 332 
High molecular weight DNA was prepared as follows. Heparinised blood from two mice 333 
infected with P. chabaudi AS (blood passaged parasites, days seven & eight post-334 
infection) was pooled, diluted 1:3 in PBS, and passed through a Plasmodipur (Euro-335 
Diagnostica) filter. Erythrocyte membranes were removed by saponin lysis (0.15% in ice 336 
cold PBS). Parasitised erythrocytes were recovered by centrifugation (2000g 10 min 337 
4 °C) and washed twice in ice cold PBS. The cell pellet was taken up in 50mM Tris HCl 338 
pH 7.5, 50mM EDTA pH8.0, 100mM NaCl, 0.5% SDS and digested with RNase A 339 
(1mg/ml, Life Technologies) for 30 min at 37°C. Proteinase K (Roche) was added to a 340 
final concentration of 1mg/ml, incubated at 45°C overnight, followed by extraction with 341 
phenol chloroform and ethanol precipitation. 342 
For preparation of long-read sequencing libraries, 5μg of P. c. chabaudi AS genomic 343 
DNA was sheared to 20-25kb by passing through a 25mm blunt ended needle. SMRT 344 
bell template libraries were generated using the Pacific Biosciences issued protocol (20 345 
kb Template Preparation Using BluePippin™ Size-Selection System). After 7kb-20kb 346 
size-selection using the BluePippin™ Size-Selection System (Sage Science,  347 
Beverly, MA) the library was sequenced using P6 polymerase and chemistry version 4 348 
(P6C4) on 5 single-molecule real-time (SMRT) cells, each with a 240 minutes movie 349 
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length. The five SMRT cells were processed using a Pacific Biosciences RSII. Reads 350 
were filtered using SMRT portal v2.2 with default parameters (minimum subread length 351 
50, minimum polymerase read quality 75, minimum polymerase read length 50). The 352 
yield was 258214 reads totaling 1.51Gb, with read N50 9003bp and read quality 0.833. 353 
The reads were assembled using HGAP v2.2.043 with expected coverage 75 and other 354 
parameters as default.  355 
The 28 unitigs from the HGAP assembly were BLASTed against the P. chabaudi AS v2 356 
assembly14 to identify sequences relating to nuclear, mitochondrial and apicoplast 357 
genomes. Four unitigs were found to be mouse contamination. Fourteen unitigs 358 
represented the fourteen chromosomes from the v2 assembly including most of the 359 
unplaced contigs from v2 and some additional new sequence. All fourteen had telomeric 360 
repeats at both ends. The only major rearrangement between the assemblies was between 361 
the ends of chromosomes 6 and 13. We mapped Quiver-corrected PacBio reads against 362 
v2 and v3 assemblies and confirmed that the v3 assembly was correct. However, we 363 
noticed base errors and in particular many indels in the v3 assembly due to the relatively 364 
high error rate of PacBio sequencing. The v2 assembly had had the benefit of Sanger and 365 
Illumina technologies such that at the base level it was more accurate than the PacBio 366 
assembly. Therefore we generated 2x250bp paired-end pseudoreads from the v2 367 
assembly with a fragment size of 600bp to a depth of 50x and used these to correct the v3 368 
assembly using iCORN244. We transferred gene models from the v2 assembly to the 369 
corrected v3 assembly using RATT44. We then trained Augustus v2.5.545 using the v2 370 
gene models with default parameters and predicted a new set of models for the corrected 371 
v3 assembly. We kept only those, which did not overlap with the RATT-transferred gene 372 
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models. We then manually assessed the transferred models, annotated the new Augustus 373 
models and renamed the locus tags. In general we added a zero to the end of the v2 locus 374 
tags, but where a gene did not exist in v2 or had moved we added an odd number at the 375 
end. We maintained numerical ordering of locus tags across each chromosome so that 376 
they reflect relative chromosomal location. 377 
 378 
Sequence analysis of pir genes 379 
Pir gene sub clade assignments were initially made using Hidden Markov Models 380 
(HMMs) built from the rodent malaria pir subclades published in Otto et al.14. There were 381 
some discrepancies between the two sets, e.g. where the clade in the published tree did 382 
not agree with the top HMM hit.  In particular we identified three members of the S3 383 
subclade, which was not previously thought to be present in P. chabaudi. We used 384 
hmmsearch from HMMer i1.1rc346 with an E-value cutoff of 1e-10 and took the best hit 385 
to a subclade. We thus identified 207 pir genes which we could assign to a rodent malaria 386 
parasite (RMP) pir subclade, while a further five genes could not be classified into 387 
existing subfamilies (PCHAS_0401400, PCHAS_0602000 and PCHAS_1247000). 388 
HMM assignments of L2 pirs in P. berghei were consistent with the original tree-based 389 
classification presented in Otto et al. (2014). 390 
We used FIRE v1.1a47 to identify putative promoter sequences upstream of genes in the 391 
AAPLs and ChAPLs. Firstly we used RNA-seq data from the study to determine 5’ 392 
unstranslated regions (UTRs) of pir genes and then manually identified untranscribed 393 
regions upstream of each UTR, reaching until the proximal UTR of the next upstream 394 
gene. Where there was insufficient RNA-seq data or other ambiguity, we did not identify 395 
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a region. This was successful for 27/32 ChAPL genes and 22/28 AAPL genes. We then 396 
defined AAPL and ChAPL genes as two distinct expression clusters and ran FIRE with --397 
exptype=discrete and --nodups=1 options. 398 
Sequence alignments were performed using Muscle48 with default parameters and 399 
visualized using Jalview49. 400 
 401 
Regression analysis of pir genes against parasitological parameters 402 
DESeq2 was used to determine whether variation in gene expression between parasite 403 
populations in different mice was correlated with parasitological parameters such as 404 
parasitaemia and time of recrudescence50. In particular we found that the expression level 405 
during the acute phase of 152 genes was correlated with the time to recrudescence across 406 
nine mice (p-value < 0.01; fold change >= 2). We discretized the time in days at 407 
recrudescence as follows: mice 214 (32 days), 421 (31 days), 427 (30 days) were short, 408 
2014 (34 days), 2114 (36 days), 452 (33 days) and 456 (34 days) were medium, 211 (43 409 
days) and 212 (39 days) were long. We then used this single discrete factor in the 410 
DESeq2 design formula. Those genes where expression level during the acute phase was 411 
negatively correlated with time at recrudescence were, with a single exception, pir genes 412 
from 3L, 6L and 6R subtelomeres (Table S6). These are the three ChAPLs and another 413 
L1-rich locus (4R). Interestingly, the strongest effect was from an exported gene of 414 
unknown function (PCHAS_1201300). The strongest positive effects were from pir 415 
genes in AAPLs. 416 
 417 
Mixed infection  418 
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Transgenic lines of Plasmodium chabaudi AS expressing mCherry or mNeonGreen under 419 
the control of the constitutive promoter EF1α were generated by transfection with the 420 
plasmid PcEFp230p_mCherry and PcEFp230p_mNeonGreen, respectively. These 421 
plasmids targeted the silent 230p genomic locus, and were generated by replacement of 422 
the ssu rRNA locus of pPc-mCHCAM, described in51, with the P. chabaudi p230p locus 423 
(PCHAS_03_v3  276,451-283,284). For PcEFp230p_mNeonGreen, the mCherry tag was 424 
replaced with mNeonGreen52. Parasites were cycled ON and OFF acid water containing 425 
pyrimethamine to select for stably transfected parasites, and cloned by serial dilution. The 426 
insertion was verified by PCR amplification and Southern blot analysis and fluorochrome 427 
expression by Flow cytometry analysis (Figure S9). mNeonGreen-expressing parasites 428 
were then serially blood passaged (SBP) 10 times while mCherry-expressing parasites 429 
were mosquito transmitted (MT) into donor mice. Both parasites were then mixed at 430 
different ratios and 105 infected erythrocytes were injected i.p. into ten recipient mice per 431 
group. Competition between parasite lines as well as parasitaemia and pathology were 432 
then monitored in recipient mice. To determine the ratio of mNeonGreen- and mCherry-433 
expressing parasites during infection, tail blood was collected and stained with Hoechst 434 
33342 (New England Biolab). Samples were acquired on a BD LSRII flow cytometer and 435 
data were analysed with FlowJo software (TreeStar).  436 
 437 
Clodronate liposomes treatment 438 
B6.RAG-1-/- mice were treated with 200uL i.v. of either saline (Sigma; negative control) 439 
or clodronate liposomes (clodronateliposomes.org).  Flow cytometric analysis was 440 
carried out to assess the depletion of phagocytic cells. Single-cell suspensions of 441 
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splenocytes were prepared, , and cells enumerated 24h after in vivo treatment. After 442 
staining with Zombie Aqua (Biolegend) for live/dead discrimination, cells were stained 443 
with monoclonal antibodies using appropriate combinations of fluorochromes (CD11c-444 
BV786, CD169-BV605, F4/80-BV421, Ly6G-PerCPCy5.5, MHCII-FITC, Ter119-PE-445 
Cy7, CD68-PE, Ly6c-APC-Cy7, CD11b-AF647, all from Biolegend). The samples were 446 
acquired on a BD Fortessa/X20 (BD Biosciences) using Diva acquisition software (BD 447 
Biosciences). FlowJo (Tree Star) software was used to analyze the data. 448 
To determine the role of T-, B- and phagocytic cells in the selection of virulent parasites, 449 
B6.RAG-1-/- mice were treated with saline or clodronate liposomes as described above at 450 
days -1 and 4 after i.p. infection with 105 iRBCs containing a mix of Neon-Green-451 
expressing SBP parasites and mCherry-expressing MT parasites (see "Mixed infections" 452 
section).  453 
 454 
Data availability 455 
RNA-seq datasets used in this study have been submitted to the European Nucleotide 456 
Archive (ENA) under study accession ERP017479. These datasets are described further 457 
in Supplementary Table 10. The Pacific Biosciences RSII genomic sequencing reads, 458 
used to generate the Plasmodium chabaudi chabaudi AS v3 genome sequence, have been 459 
submitted to the ENA under experiment accession ERX613966. The assembled genome 460 
sequence and annotation can be accessed from GeneDB 461 
(http://www.genedb.org/Homepage/Pchabaudi) and PlasmoDB 462 
(http://plasmodb.org/plasmo/). The authors declare that no competing interests exist. 463 
 464 
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Figure legends 649 
Figure 1: Chronic infections modify the transcriptome of P. chabaudi independently 650 
of the adaptive immune response.  651 
Parasitaemias over the course of infection in (A) 10 wild-type C57Bl/6 mice, (B) 10 652 
B6.μMT-/- mice and (C) 10 TCRα-/- mice are shown on the left panels. Parasite mRNAs 653 
were collected from 9 wild-type C57Bl/6 mice, 5 B6.μMT-/- mice and 3 TCRα-/- mice 654 
selected randomly at the time points indicated by the red arrows. On the right panels, hot 655 
pie diagrams show expression levels (black and white inner circles) and fold changes 656 
(coloured outer circles) for genes expressed more highly (FDR <= 0.01, fold change >= 657 
2) in the chronic and acute phases. Genes are classified into groups according to several 658 
categories including: subtelomeric genes (subtel.); genes associated with red blood cell 659 
invasion (invasion); genes associated with gametocytogenesis (sexual) and pir genes 660 
(highlighted in brown).  661 
 662 
Figure 2: Chronic infections are characterized by the expression of distinctive 663 
clusters of pir genes in P. chabaudi. 664 
(A) Chronic Associated Pir Loci (ChAPL), and (B) Acute Associated Pir Loci (AAPL) 665 
are shown in the context of the subtelomeric region from the telomeric repeats to the last 666 
pir or fam-a gene. Those genes co-expressed across mice over the course of infection are 667 
highlighted in orange. (C) Heatmap of pir gene expression at ChAPL and AAPL loci, 668 
showing mean-normalised RPKM values for 10 wild type C57Bl/6 mice, four B6.μMT-/- 669 
mice and three TCRα-/- mice infected by mosquito bites. Each column represents values 670 
obtained from an individual mouse. Samples were collected from the same mice during 671 
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the acute and chronic (chro.) phases of infection. On the side, numbers indicate 672 
chromosomes and letters indicate the location on that chromosome: L for left hand end, R 673 
for right hand end. ChAPLs and AAPLs are highlighted. For each gene, red represents its 674 
maximal expression, green its minimal expression. The absolute maximum and minimum 675 
values for each gene are shown in a separate heatmap.  676 
 677 
Figure 3: Chronic infections select for virulent P. chabaudi parasites expressing 678 
distinctive clusters of pir genes. 679 
Donor mice were infected by mosquito bites. (A) Parasites were subsequently passaged 680 
into naïve recipient mice after one, three, four or six weeks (n=15 mice per group). (B) 681 
Individual parasites were cloned during the acute and chronic phases of infection. After 682 
their expansion, clonal populations of parasites were used to infect recipient mice (n= 5 683 
mice per clone). In (A) and (B), we show maximum parasitaemia, temperature change 684 
and weight change for recipient mice compared to mice directly infected by mosquito 685 
bites (MT; blue dotted line) or with serially blood passaged parasites (SBP; red dotted 686 
line). Each dot represents the mean ± standard error of the mean (SEM) of 5 individual 687 
mice. Each group has been compared to mice infected with 105 MT parasites (*P<0,05; 688 
**P<0,01; ***P<0,001, two-sided Mann Whitney Test). (C) Heatmap of pir gene 689 
expression at ChAPLs and AAPLs in three acute and three chronic clones. The first three 690 
columns represent cloned parasite lines derived from from the acute phase (f, a, b), the 691 
next three columns represent cloned lines from the chronic phase (k, n, p) from 3 692 
individual mice. On the side, chromosomes numbers are indicated as well as the location 693 
on that chromosome: L for left hand, R for right hand. ChAPLs and AAPLs are 694 
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highlighted. For each gene, red represents its maximal expression, green its minimal 695 
expression. The absolute maximum and minimum values for each gene are shown in a 696 
separate heatmap.  697 
 698 
Figure 4: Chronicity and virulence of infection are dictated by the initial 699 
composition of P. chabaudi population. 700 
Parasites tagged with mCherry (Fluo 1) were Mosquito-Transmitted (MT), and 701 
mNeonGreen (Fluo 2) tagged parasites were Serially Blood-Passaged (SBP). Different 702 
proportions of the two were used to infect recipient mice by i.p. injection of 105 parasites 703 
(n= 10 mice per group). As a control, a group of 10 recipient mice was infected by i.p. 704 
injection of 104 SBP parasites. The mean percentage of parasites being SBP (as 705 
determined by flow cytometry) is indicated (upper panel). We show maximum 706 
parasitaemia, temperature change, weight change (middle panel) and time of 707 
recrudescence (lower panel) for each group compared to mice infected with 100% MT 708 
parasites (blue dotted line) or 100% SBP parasites (red dotted line).  Each dot represents 709 
the mean ± standard error of the mean (SEM) for each group of 10 mice. Each group has 710 
been compared to mice infected with 105 SBP parasites (*P<0,05; **P<0,01; 711 
***P<0,001, two-sided Mann Whitney Test). 712 
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